These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17475624)

  • 1. Silencing of insulin-like growth factor-binding protein-2 in human glioblastoma cells reduces both invasiveness and expression of progression-associated gene CD24.
    Fukushima T; Tezuka T; Shimomura T; Nakano S; Kataoka H
    J Biol Chem; 2007 Jun; 282(25):18634-18644. PubMed ID: 17475624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of insulin-like growth factor binding protein-2 (IGFBP-2) in glioblastoma.
    Fukushima T; Kataoka H
    Anticancer Res; 2007; 27(6A):3685-92. PubMed ID: 17970029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor binding protein-2 regulates β-catenin signaling pathway in glioma cells and contributes to poor patient prognosis.
    Patil SS; Gokulnath P; Bashir M; Shwetha SD; Jaiswal J; Shastry AH; Arimappamagan A; Santosh V; Kondaiah P
    Neuro Oncol; 2016 Nov; 18(11):1487-1497. PubMed ID: 27044294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
    Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
    J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
    Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of serum levels and tissue expression of two genes IGFBP-2 and IGFBP-3 act as potential biomarker for predicting the progression and survival in patients with glioblastoma multiforme.
    Abdolhoseinpour H; Mehrabi F; Shahraki K; Khoshnood RJ; Masoumi B; Yahaghi E; Goudarzi PK
    J Neurol Sci; 2016 Jul; 366():202-206. PubMed ID: 27288807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IIp45, an insulin-like growth factor binding protein 2 (IGFBP-2) binding protein, antagonizes IGFBP-2 stimulation of glioma cell invasion.
    Song SW; Fuller GN; Khan A; Kong S; Shen W; Taylor E; Ramdas L; Lang FF; Zhang W
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):13970-5. PubMed ID: 14617774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The microRNA-302b-inhibited insulin-like growth factor-binding protein 2 signaling pathway induces glioma cell apoptosis by targeting nuclear factor IA.
    Lee CC; Chen PH; Ho KH; Shih CM; Cheng CH; Lin CW; Cheng KT; Liu AJ; Chen KC
    PLoS One; 2017; 12(3):e0173890. PubMed ID: 28323865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes.
    Wang H; Wang H; Shen W; Huang H; Hu L; Ramdas L; Zhou YH; Liao WS; Fuller GN; Zhang W
    Cancer Res; 2003 Aug; 63(15):4315-21. PubMed ID: 12907597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
    Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
    Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deregulation of IGF-binding proteins -2 and -5 contributes to the development of endocrine resistant breast cancer in vitro.
    Hawsawi Y; Humphries MP; Wright A; Berwick A; Shires M; Al-Kharobi H; El-Gendy R; Jove M; Twelves C; Speirs V; Beattie J
    Oncotarget; 2016 May; 7(22):32129-43. PubMed ID: 27050076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of glycosyltransferase PomGnT1 in glioblastoma progression.
    Lan J; Guo P; Lin Y; Mao Q; Guo L; Ge J; Li X; Jiang J; Lin X; Qiu Y
    Neuro Oncol; 2015 Feb; 17(2):211-22. PubMed ID: 25085363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin (HAI-2/PB) in human glioblastomas: implication for anti-invasive role of HAI-2/PB in glioblastoma cells.
    Hamasuna R; Kataoka H; Meng JY; Itoh H; Moriyama T; Wakisaka S; Koono M
    Int J Cancer; 2001 Aug; 93(3):339-45. PubMed ID: 11433397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cytomegalovirus US28 found in glioblastoma promotes an invasive and angiogenic phenotype.
    Soroceanu L; Matlaf L; Bezrookove V; Harkins L; Martinez R; Greene M; Soteropoulos P; Cobbs CS
    Cancer Res; 2011 Nov; 71(21):6643-53. PubMed ID: 21900396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer.
    Mehrian-Shai R; Chen CD; Shi T; Horvath S; Nelson SF; Reichardt JK; Sawyers CL
    Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5563-8. PubMed ID: 17372210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of β-arrestin 1 suppresses glioblastoma cell malignant progression vis inhibition of Src signaling.
    Lan T; Wang H; Zhang Z; Zhang M; Qu Y; Zhao Z; Fan X; Zhan Q; Song Y; Yu C
    Exp Cell Res; 2017 Aug; 357(1):51-58. PubMed ID: 28442265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAX6 suppresses the invasiveness of glioblastoma cells and the expression of the matrix metalloproteinase-2 gene.
    Mayes DA; Hu Y; Teng Y; Siegel E; Wu X; Panda K; Tan F; Yung WK; Zhou YH
    Cancer Res; 2006 Oct; 66(20):9809-17. PubMed ID: 17047041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-κB signaling that promotes colon cancer progression.
    Ben-Shmuel A; Shvab A; Gavert N; Brabletz T; Ben-Ze'ev A
    Oncogene; 2013 Jul; 32(27):3220-30. PubMed ID: 22869145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20.
    Marucci G; Morandi L; Magrini E; Farnedi A; Franceschi E; Miglio R; Calò D; Pession A; Foschini MP; Eusebi V
    Virchows Arch; 2008 Dec; 453(6):599-609. PubMed ID: 18953566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGFBP2 promotes immunosuppression associated with its mesenchymal induction and FcγRIIB phosphorylation in glioblastoma.
    Liu Y; Song C; Shen F; Zhang J; Song SW
    PLoS One; 2019; 14(9):e0222999. PubMed ID: 31560714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.